Quick Order Cart

Cat. No. ARG44014

NR4A1 Knockout HEK293T Cell Line

  • Product Type:

    In Stock Cell Lines

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The NR4A1 Knockout HEK293T Cell Line is a CRISPR/Cas9-edited knockout cell line that disrupts the NR4A1 gene in HEK293T human embryonic kidney epithelial cells. NR4A1 is a stress-inducible orphan nuclear receptor and transcription factor that regulates apoptosis via transactivation of BCL2L11 (Bim) and BNIP3L (NIX), and controls metabolic pathways through FBP1 and PEPCK. It integrates signals from MAPK pathways and interacts with cofactors such as p300. Knockout of NR4A1 in HEK293T provides a powerful model to study apoptosis, metabolic regulation, and inflammation. Applications include flow cytometric cell death assays, metabolic flux analysis, luciferase reporter gene assays, and RT-qPCR-based analysis of NR4A1 target genes. Contact Ascent Research for additional details.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    NR4A1

    Gene Identifier

    NCBI Gene ID 3164

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The NR4A1 Knockout HEK293T Cell Line is a targeted CRISPR/Cas9-edited knockout cell line that disrupts the NR4A1 locus, effectively ablating NR4A1 expression in HEK293T cells. This knockout model enables researchers to dissect NR4A1-specific functions in transcriptional control, apoptosis, and metabolic signaling, free from interference by endogenous NR4A1 activity.

HEK293T cells are a human embryonic kidney epithelial cell line that stably expresses the SV40 large T-antigen, facilitating high levels of transient transfection and protein expression. Their robust growth and extensive characterization make them a favored host for genetic perturbation studies, providing a reproducible platform for investigating gene function and cellular signaling.

NR4A1, an immediate-early orphan nuclear receptor, is rapidly induced by diverse stimuli such as growth factors, cytokines, cAMP, and calcium. Activation involves phosphorylation by ERK1/2, p38, and JNK upstream kinases. NR4A1 acts as a transcription factor, directly promoting expression of pro-apoptotic genes (BCL2L11/Bim, BNIP3L/NIX) and metabolic regulators (FBP1, PEPCK), while modulating inflammatory cytokines. It associates with coactivators p300/SRC-1 and corepressors NCoR/SMRT, and participates in heterodimer formation with RXR and functional interaction with PPAR??. Consequently, NR4A1 integrates signals from MAPK/ERK, PI3K/AKT, and Wnt/??-catenin pathways to effect downstream apoptosis and metabolic responses.

In HEK293T cells, NR4A1 knockout provides a clean background to dissect its involvement in stress-induced apoptosis and metabolic reprogramming. The well-studied MAPK and PI3K/AKT signaling competency of HEK293T cells allows researchers to precisely map NR4A1-dependent versus -independent events upon stimulation. This model is particularly valuable for examining mechanisms linking extracellular signals to mitochondrial apoptosis and for identifying NR4A1 transcriptional targets in a human epithelial context.

Typical applications include apoptosis analysis via flow cytometry coupled with caspase-3/7 activity assays, metabolic flux analysis to monitor changes in glucose utilization and mitochondrial respiration, and ChIP-qPCR or luciferase reporter assays to probe NR4A1 transcriptional activity and promoter occupancy. The knockout cell line is also suitable for investigating steroidogenic enzyme gene regulation, neuroprotective signaling, and cytokine-driven inflammatory responses, utilizing techniques such as RT-qPCR and western blotting. For additional technical details or assistance, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)